Scaccabarozzi: “1,400 billion dollars for research and development in the world over the next 5 years”

“There are $ 1.4 trillion” available in R&D investments over the next 5 years “globally. “The challenge for our country is to bring as much of it as possible to us, because the competition to attract resources is now taking place worldwide, but we need reforms. We have an old system, based on spending ceilings, which is Some Regions are going even further in this direction, giving doctors ceilings on the cost items. This is an old system, which was implemented in Italy 15 years ago and in 15 years the world has changed even in the care we have available”. Thus Massimo Scaccabarozzi, president of Janssen Italia and Head of External Affairs Johnson & Johnson Italy, who spoke at the presentation of the report produced by Censis in collaboration with Janssen Italia on healthcare in our country, on the occasion of the first edition of ‘The Italian Health Day’, which was held today in Rome at the Ministry of Health. “Clinical research – he underlined – represents the lifeblood of our company, just think that there are 14 new molecules on which Janssen is working, especially in the oncology and immunology fields, to make them available to patients”.